A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction
about
The Role of Glycosylation in Breast Cancer Metastasis and Cancer ControlChallenges in Antibody Development against Tn and Sialyl-Tn AntigensTumour-associated carbohydrate antigens in breast cancer.A glycobiology review: carbohydrates, lectins and implications in cancer therapeuticsInsights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue.The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccinesA comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endotheliumEffective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigenTumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.Simple sugars to complex disease--mucin-type O-glycans in cancer.Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors.Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenesEngineering O-Glycosylation Points in Non-extended Peptides: Implications for the Molecular Recognition of Short Tumor-Associated Glycopeptides
P2860
Q26777141-F9E0D5EA-4510-4FC9-90D6-E73A30E84AE0Q26798183-92A61A12-DD31-4F83-90A8-83F085AB6990Q34048052-C53C2679-A8E1-414B-A443-996BF05FD83DQ34524965-88012F8E-433D-4064-B2EB-1F96ECBEC115Q35649524-61DA4E16-BAF6-4A45-9923-FCF30A19CCF1Q35686754-9C9C3281-FD5C-4003-A212-D117FE2E5C20Q35794259-C3D06E8E-C2E7-422F-AB96-BD980A33A1A0Q36200540-AD84D184-5978-4B00-BC5B-66A417264F48Q36476824-CFEA8E10-B660-47F1-883E-AD88D2B5E638Q37222147-2E088E28-BBE2-4966-B092-4DFDCDF2E8BEQ37512647-A09605A7-52EF-445F-B8DB-F94BD383F3F3Q38366325-5C4805B8-F27A-4F69-BE92-4495EE245AA5Q39162905-2A1E73E4-750B-4782-8F91-69F2B7F68410Q39179715-7D8B49C1-AE2F-4582-9636-F7666DC92360Q41568866-B8434006-5892-4149-BA8D-45A8048EAEA7Q56889497-F8B36993-2643-4B2D-B49A-D6309ED961CBQ57515385-65236DC8-7C57-479B-961D-105E3289BD18
P2860
A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A newly generated functional a ...... phatic endothelium interaction
@en
A newly generated functional a ...... hatic endothelium interaction.
@nl
type
label
A newly generated functional a ...... phatic endothelium interaction
@en
A newly generated functional a ...... hatic endothelium interaction.
@nl
prefLabel
A newly generated functional a ...... phatic endothelium interaction
@en
A newly generated functional a ...... hatic endothelium interaction.
@nl
P2093
P2860
P356
P1433
P1476
A newly generated functional a ...... phatic endothelium interaction
@en
P2093
Alfonso Colombatti
Anna Coslovi
Carla Danussi
Cristiana Campa
Fulvio Uggeri
Maria T Mucignat
Paola Spessotto
Sergio Paoletti
P2860
P304
P356
10.1093/GLYCOB/CWP085
P577
2009-06-15T00:00:00Z